Latest hysterectomy Stories

Women still have hot flushes and night sweats years after the menopause finds a new study published today in BJOG: An International Journal of Obstetrics and Gynaecology. Hot flushes and night sweats (HF/NS) are the main physical signs of the menopause, however their prevalence, frequency, severity and duration vary considerably. The average age of the menopause in US and European women is 50-51 years and it is generally assumed that HF/NS last between 2 to 5 years. This study looked...

Post-menopausal women who experience new onset breast tenderness after starting combination hormone therapy may have an increased risk of breast cancer compared to women who don't experience breast tenderness, a study by researchers at UCLA's Jonsson Comprehensive Cancer Center has shown. One reason for this may be that their breasts are becoming more dense. The new onset tenderness was much more pronounced after initiation of estrogen and progestin therapy than in women getting estrogen...

University of California Los Angeles study suggests reducing iron may lower age-related brain disease risk The human body has a love-hate relationship with iron. Just the right amount is needed for proper cell function, yet too much is associated with brain diseases like Alzheimer's and Parkinson's. Science knows that men have more iron in their bodies and brains than women. These higher levels may be part of the explanation for why men develop these age-related neurodegenerative...

BEDFORD, Mass., Sept. 28, 2011 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today celebrates 10 years of the availability and success of its NovaSure endometrial ablation system. Since 2001, more than one and a half million women have been treated with the NovaSure system to reduce or eliminate...

Women taking postmenopausal hormone replacement therapy (HRT) may have an increased risk of severe asthma attacks requiring hospitalization, scientists warn. A new study, which will be presented today (27 September 2011) at the European Respiratory Society's Annual Congress in Amsterdam, adds to the debate over the health effects of the drug which helps women through the menopause. Previous studies have found a link between asthma and HRT, but this is the first to suggest that the drug...

Uterine leiomyomas, also called fibroids, cause a very significant burden to women's health. They are benign tumors that occur in 60% of women by the age of 45 years and cause symptoms such as abdominal pain and discomfort, and abnormal bleeding, in about half of the cases. Fibroids are also an important cause of infertility. These tumors are the most common medical reason for hysterectomy. Considering the clinical importance of fibroids, relatively little has been known about the...

SAN DIEGO, Aug. 18, 2011 /PRNewswire/ -- A forensic researcher, Lindy Hess was 32 when she was diagnosed with cervical cancer in 2005. Hess used her investigative techniques to determine what treatment would work for her. And, like half a million other Americans, she traveled outside the country for a natural approach to cancer care. According to TMD Limited, a medical tourism company, nearly 10,000 people leave the US every week to get medical treatment, and most of them travel to...

CHICAGO, Aug. 17, 2011 /PRNewswire-USNewswire/ -- Women's Health Foundation (WHF), in collaboration with the Association for Pelvic Organ Prolapse Support (APOPS) announced today that they will be representing female patients' stories who have undergone transvaginal mesh surgical treatment for pelvic organ prolapse at an upcoming FDA meeting in Washington, D.C. This meeting is in response to the FDA's recent public health notification warning regarding the safety of transvaginal mesh....

SHELTON, Conn., Aug. 3, 2011 /PRNewswire/ -- Cara Therapeutics, Inc. today announced the dosing of the first patient in a Phase II clinical trial of its peripherally-selective, kappa opioid agonist, CR845, for the treatment of acute post-operative pain. The double-blind, placebo-controlled trial is expected to enroll a minimum of 200 patients at multiple clinical sites in the United States, and will evaluate the efficacy and safety of intravenous CR845 administered both pre- and...

PAOLI, Pa., June 27, 2011 /PRNewswire/ -- A radiologic technology, which functions like a 'human GPS system,' and provides more precise results while using less radiation, is being used to treat patients with symptomatic uterine fibroids exclusively at Paoli Hospital. Dr. Atul Gupta, director of interventional radiology, is treating patients as part of a first-ever clinical trial. To view the multimedia assets associated with this release, please click...